118 related articles for article (PubMed ID: 9037066)
1. Developmental analysis and subcellular localization of the murine homologue of ELL.
Thirman MJ; Diskin EB; Bin SS; Ip HS; Miller JM; Simon MC
Proc Natl Acad Sci U S A; 1997 Feb; 94(4):1408-13. PubMed ID: 9037066
[TBL] [Abstract][Full Text] [Related]
2. Cloning of ELL, a gene that fuses to MLL in a t(11;19)(q23;p13.1) in acute myeloid leukemia.
Thirman MJ; Levitan DA; Kobayashi H; Simon MC; Rowley JD
Proc Natl Acad Sci U S A; 1994 Dec; 91(25):12110-4. PubMed ID: 7991593
[TBL] [Abstract][Full Text] [Related]
3. A carboxy-terminal domain of ELL is required and sufficient for immortalization of myeloid progenitors by MLL-ELL.
DiMartino JF; Miller T; Ayton PM; Landewe T; Hess JL; Cleary ML; Shilatifard A
Blood; 2000 Dec; 96(12):3887-93. PubMed ID: 11090074
[TBL] [Abstract][Full Text] [Related]
4. The elongation domain of ELL is dispensable but its ELL-associated factor 1 interaction domain is essential for MLL-ELL-induced leukemogenesis.
Luo RT; Lavau C; Du C; Simone F; Polak PE; Kawamata S; Thirman MJ
Mol Cell Biol; 2001 Aug; 21(16):5678-87. PubMed ID: 11463848
[TBL] [Abstract][Full Text] [Related]
5. ELL-associated factor 2 (EAF2), a functional homolog of EAF1 with alternative ELL binding properties.
Simone F; Luo RT; Polak PE; Kaberlein JJ; Thirman MJ
Blood; 2003 Mar; 101(6):2355-62. PubMed ID: 12446457
[TBL] [Abstract][Full Text] [Related]
6. Physical interaction and functional antagonism between the RNA polymerase II elongation factor ELL and p53.
Shinobu N; Maeda T; Aso T; Ito T; Kondo T; Koike K; Hatakeyama M
J Biol Chem; 1999 Jun; 274(24):17003-10. PubMed ID: 10358050
[TBL] [Abstract][Full Text] [Related]
7. Retrovirus-mediated gene transfer of MLL-ELL transforms primary myeloid progenitors and causes acute myeloid leukemias in mice.
Lavau C; Luo RT; Du C; Thirman MJ
Proc Natl Acad Sci U S A; 2000 Sep; 97(20):10984-9. PubMed ID: 10995463
[TBL] [Abstract][Full Text] [Related]
8. Identification and purification of the Holo-ELL complex. Evidence for the presence of ELL-associated proteins that suppress the transcriptional inhibitory activity of ELL.
Shilatifard A
J Biol Chem; 1998 May; 273(18):11212-7. PubMed ID: 9556611
[TBL] [Abstract][Full Text] [Related]
9. EAF1, a novel ELL-associated factor that is delocalized by expression of the MLL-ELL fusion protein.
Simone F; Polak PE; Kaberlein JJ; Luo RT; Levitan DA; Thirman MJ
Blood; 2001 Jul; 98(1):201-9. PubMed ID: 11418481
[TBL] [Abstract][Full Text] [Related]
10. ELL and EAF1 are Cajal body components that are disrupted in MLL-ELL leukemia.
Polak PE; Simone F; Kaberlein JJ; Luo RT; Thirman MJ
Mol Biol Cell; 2003 Apr; 14(4):1517-28. PubMed ID: 12686606
[TBL] [Abstract][Full Text] [Related]
11. Identification, cloning, expression, and biochemical characterization of the testis-specific RNA polymerase II elongation factor ELL3.
Miller T; Williams K; Johnstone RW; Shilatifard A
J Biol Chem; 2000 Oct; 275(41):32052-6. PubMed ID: 10882741
[TBL] [Abstract][Full Text] [Related]
12. Cloning and characterization of the EAP30 subunit of the ELL complex that confers derepression of transcription by RNA polymerase II.
Schmidt AE; Miller T; Schmidt SL; Shiekhattar R; Shilatifard A
J Biol Chem; 1999 Jul; 274(31):21981-5. PubMed ID: 10419521
[TBL] [Abstract][Full Text] [Related]
13. An RNA polymerase II elongation factor encoded by the human ELL gene.
Shilatifard A; Lane WS; Jackson KW; Conaway RC; Conaway JW
Science; 1996 Mar; 271(5257):1873-6. PubMed ID: 8596958
[TBL] [Abstract][Full Text] [Related]
14. Drosophila ELL is associated with actively elongating RNA polymerase II on transcriptionally active sites in vivo.
Gerber M; Ma J; Dean K; Eissenberg JC; Shilatifard A
EMBO J; 2001 Nov; 20(21):6104-14. PubMed ID: 11689450
[TBL] [Abstract][Full Text] [Related]
15. Structure and function of RNA polymerase II elongation factor ELL. Identification of two overlapping ELL functional domains that govern its interaction with polymerase and the ternary elongation complex.
Shilatifard A; Haque D; Conaway RC; Conaway JW
J Biol Chem; 1997 Aug; 272(35):22355-63. PubMed ID: 9268387
[TBL] [Abstract][Full Text] [Related]
16. ELL2, a new member of an ELL family of RNA polymerase II elongation factors.
Shilatifard A; Duan DR; Haque D; Florence C; Schubach WH; Conaway JW; Conaway RC
Proc Natl Acad Sci U S A; 1997 Apr; 94(8):3639-43. PubMed ID: 9108030
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of the MEN/ELL protein, an RNA polymerase II elongation factor, results in transformation of Rat1 cells with dependence on the lysine-rich region.
Kanda Y; Mitani K; Kurokawa M; Yamagata T; Yazaki Y; Hirai H
J Biol Chem; 1998 Feb; 273(9):5248-52. PubMed ID: 9478981
[TBL] [Abstract][Full Text] [Related]
18. The elongation factor ELL (eleven-nineteen lysine-rich leukemia) is a selective coregulator for steroid receptor functions.
Pascual-Le Tallec L; Simone F; Viengchareun S; Meduri G; Thirman MJ; Lombès M
Mol Endocrinol; 2005 May; 19(5):1158-69. PubMed ID: 15650021
[TBL] [Abstract][Full Text] [Related]
19. A novel variant form of MLL-ELL fusion transcript with t(11;19)(q23;p13.1) in chronic myelomonocytic leukemia transforming to acute myeloid leukemia.
Kakihana K; Kubo F; Wakabayashi S; Kurosu T; Miki T; Murakami N; Miura O
Cancer Genet Cytogenet; 2008 Jul; 184(2):109-12. PubMed ID: 18617060
[TBL] [Abstract][Full Text] [Related]
20. Nonredundant roles of the elongation factor MEN in postimplantation development.
Mitani K; Yamagata T; Iida C; Oda H; Maki K; Ichikawa M; Asai T; Honda H; Kurokawa M; Hirai H
Biochem Biophys Res Commun; 2000 Dec; 279(2):563-7. PubMed ID: 11118326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
